Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26161
Title: | EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism. | Austin Authors: | Gomez, Juliana;Areeb, Zammam;Stuart, Sarah F;Nguyen, Hong P T;Paradiso, Lucia;Zulkifli, Ahmad;Madan, Sonakshi;Rajagopal, Vijay;Montgomery, Magdalene K;Gan, Hui K ;Scott, Andrew M ;Jones, Jordan;Kaye, Andrew H;Morokoff, Andrew P;Luwor, Rodney B | Affiliation: | Department of Neurosurgery, Hadassah Hebrew University Medical Centre, Jerusalem 91120, Israel Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia Olivia Newton-John Cancer Research Institute Department of Physiology, The University of Melbourne, Parkville, VIC 3010, Australia Cell Structure and Mechanobiology Group, Department of Biomedical Engineering, Melbourne School of Engineering, The University of Melbourne, Parkville, VIC 3010, Australia |
Issue Date: | 10-Mar-2021 | Date: | 2021 | Publication information: | Cancers 2021; 13(6): 1198 | Abstract: | Reticulocalbin 1 (RCN1) is an endoplasmic reticulum (ER)-residing protein, involved in promoting cell survival during pathophysiological conditions that lead to ER stress. However, the key upstream receptor tyrosine kinase that regulates RCN1 expression and its potential role in cell survival in the glioblastoma setting have not been determined. Here, we demonstrate that RCN1 expression significantly correlates with poor glioblastoma patient survival. We also demonstrate that glioblastoma cells with expression of EGFRvIII receptor also have high RCN1 expression. Over-expression of wildtype EGFR also correlated with high RCN1 expression, suggesting that EGFR and EGFRvIII regulate RCN1 expression. Importantly, cells that expressed EGFRvIII and subsequently showed high RCN1 expression displayed greater cell viability under ER stress compared to EGFRvIII negative glioblastoma cells. Consistently, we also demonstrated that RCN1 knockdown reduced cell viability and exogenous introduction of RCN1 enhanced cell viability following induction of ER stress. Mechanistically, we demonstrate that the EGFRvIII-RCN1-driven increase in cell survival is due to the inactivation of the ER stress markers ATF4 and ATF6, maintained expression of the anti-apoptotic protein Bcl-2 and reduced activity of caspase 3/7. Our current findings identify that EGFRvIII regulates RCN1 expression and that this novel association promotes cell survival in glioblastoma cells during ER stress. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26161 | DOI: | 10.3390/cancers13061198 | ORCID: | 0000-0003-0543-365X 0000-0002-5509-402X 0000-0001-7319-8546 0000-0002-3020-4245 |
Journal: | Cancers | PubMed URL: | 33801941 | ISSN: | 2072-6694 | Type: | Journal Article | Subjects: | EGFRvIII ER stress RCN1 apoptosis glioblastoma |
Appears in Collections: | Journal articles |
Show full item record
Page view(s)
34
checked on Nov 25, 2024
Download(s)
46
checked on Nov 25, 2024
Google ScholarTM
Check
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.